Physician

Scott D Miller, MD

According to 2025 Medicare claims, Scott Miller, MD (NPI: 1790722916) practices dermatology in the Amarillo, TX market, with the plurality of this provider's patient population coming from Potter, TX. This provider's primary affiliated billing organization is HIGH PLAINS DERMATOLOGY CENTER, P.A. (NPI: 1083667117; TIN: 751477242) and primary practice location at 79106-5959.

Miller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,877 traditional Medicare patients, billed 9,766 HCPCS/CPT codes, and received $563,645 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,320 prescription claims across 568 beneficiaries totaling $458,266 in drug costs, led by Enbrel (Etanercept). Open Payments data shows 6 records totaling $201. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $138,578 to $458,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$297K$593K2015 Medicare payment: $476,500 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $445,818 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $482,606 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $530,033 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $593,460 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $489,416 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $584,327 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $578,656 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $522,791 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $563,645 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,16712,388$476,500
20162,13611,481$445,818
20172,16411,964$482,606
20182,07712,471$530,033
20192,23417,480$593,460
20202,02412,693$489,416
20211,99812,033$584,327
20222,02711,442$578,656
20231,9739,857$522,791
20241,8779,766$563,645

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$235K$470K2015 Drug cost: $138,578 (USD; Tot_Drug_Cst)2016 Drug cost: $146,765 (USD; Tot_Drug_Cst)2017 Drug cost: $162,384 (USD; Tot_Drug_Cst)2018 Drug cost: $250,997 (USD; Tot_Drug_Cst)2019 Drug cost: $242,129 (USD; Tot_Drug_Cst)2020 Drug cost: $252,169 (USD; Tot_Drug_Cst)2021 Drug cost: $309,893 (USD; Tot_Drug_Cst)2022 Drug cost: $427,982 (USD; Tot_Drug_Cst)2023 Drug cost: $470,446 (USD; Tot_Drug_Cst)2024 Drug cost: $458,266 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015462999$138,578
2016478998$146,765
20175371,113$162,384
20185331,158$250,997
20195411,175$242,129
20205051,129$252,169
20215271,105$309,893
20225101,186$427,982
20235111,146$470,446
20245681,320$458,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more746992$92
11102Biopsy of related skin growth, first growth418472$68
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,0901,305$63
17000Destruction of precancer skin growth, 1 growth9391,167$40
17003Destruction of precancer skin growth, 2-14 growths6212,593$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EnbrelEtanercept12336$88,271
OtezlaApremilast11330$50,432
Dupixent SyringeDupilumab13364$48,175
MetronidazoleMetronidazole47713,853$22,770
Doxycycline MonohydrateDoxycycline Monohydrate1525,305$3,376

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.6$201Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Scott D. Miller, MD?

Tedicare shows public-source Medicare data for Scott D. Miller, MD (NPI 1790722916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott D. Miller, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Scott D. Miller, MD?

Scott D. Miller, MD is linked to HIGH PLAINS DERMATOLOGY CENTER, P.A. (billing NPI 1083667117) in the available physician profile data.

Does Scott D. Miller, MD have Open Payments data?

Scott D. Miller, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.